Laufenberg Lacee J, Pruznak Anne M, Navaratnarajah Maithili, Lang Charles H
Departments of Cellular and Molecular Physiology (H166), and Surgery, Penn State College of Medicine, Hershey, PA, 17033, USA.
Amino Acids. 2014 Dec;46(12):2787-98. doi: 10.1007/s00726-014-1836-6. Epub 2014 Sep 14.
The present study tested the hypothesis that sepsis-induced leucine (Leu) resistance in skeletal muscle is associated with a down-regulation of amino acid transporters important in regulating Leu flux or an impairment in the formation of the Leu-sensitive mTOR-Ragulator complex. Sepsis in adult male rats decreased basal protein synthesis in gastrocnemius, associated with a reduction in mTOR activation as indicated by decreased 4E-BP1 and S6K1 phosphorylation. The ability of oral Leu to increase protein synthesis and mTOR kinase after 1 h was largely prevented in sepsis. Sepsis increased CAT1, LAT2 and SNAT2 mRNA content two- to fourfold, but only the protein content for CAT1 (20 % decrease) differed significantly. Conversely, sepsis decreased the proton-assisted amino acid transporter (PAT)-2 mRNA by 60 %, but without a coordinate change in PAT2 protein. There was no sepsis or Leu effect on the protein content for RagA-D, LAMTOR-1 and -2, raptor, Rheb or mTOR in muscle. The binding of mTOR, PRAS40 and RagC to raptor did not differ for control and septic muscle in the basal condition; however, the Leu-induced decrease in PRAS40·raptor and increase in RagC·raptor seen in control muscle was absent in sepsis. The intracellular Leu concentration was increased in septic muscle, compared to basal control conditions, and oral Leu further increased the intracellular Leu concentration similarly in both control and septic rats. Hence, while alterations in select amino acid transporters are not associated with development of sepsis-induced Leu resistance, the Leu-stimulated binding of raptor with RagC and the recruitment of mTOR/raptor to the endosome-lysosomal compartment may partially explain the inability of Leu to fully activate mTOR and muscle protein synthesis.
脓毒症诱导的骨骼肌亮氨酸(Leu)抵抗与调节Leu通量的重要氨基酸转运体下调或Leu敏感的mTOR-Ragulator复合物形成受损有关。成年雄性大鼠的脓毒症降低了腓肠肌的基础蛋白质合成,这与mTOR激活减少有关,表现为4E-BP1和S6K1磷酸化降低。脓毒症在很大程度上阻止了口服Leu在1小时后增加蛋白质合成和mTOR激酶的能力。脓毒症使CAT1、LAT2和SNAT2 mRNA含量增加了2至4倍,但只有CAT1的蛋白质含量(降低20%)有显著差异。相反,脓毒症使质子辅助氨基酸转运体(PAT)-2 mRNA降低了60%,但PAT2蛋白质没有相应变化。脓毒症或Leu对肌肉中RagA-D、LAMTOR-1和-2、猛禽、Rheb或mTOR的蛋白质含量没有影响。在基础状态下,对照肌肉和脓毒症肌肉中mTOR、PRAS40和RagC与猛禽的结合没有差异;然而,脓毒症时对照肌肉中Leu诱导的PRAS40·猛禽减少和RagC·猛禽增加不存在。与基础对照条件相比,脓毒症肌肉中的细胞内Leu浓度升高,口服Leu在对照大鼠和脓毒症大鼠中同样进一步增加了细胞内Leu浓度。因此,虽然特定氨基酸转运体的改变与脓毒症诱导的Leu抵抗的发展无关,但Leu刺激的猛禽与RagC的结合以及mTOR/猛禽向内体-溶酶体区室的募集可能部分解释了Leu无法完全激活mTOR和肌肉蛋白质合成的原因。